Tiens Biotech Group

From Wikipedia, the free encyclopedia

Tiens Biotech

Type	Pharmaceutical
Founded	1998
Headquarters	Tianjin, People's Republic of China
Area served	People's Republic of China
Key people	Jinyuan Li, CEO Dr. Wenjun Jiao, CFO Eric Doering, General Counsel Yupeng Yan, VP HR, Admin Ping Bai, Exec. Asst. to President Cindy Lu, Secretary Socorro M. Quintero, Director Howard R. Balloch, Director Gilbert D. Raker, Director
Industry	Pharmaceutical
Products	Pharmaceutical nutrition supplement
Revenue	▲$68.7 million USD (2005)
Net income	▲$26.9 million USD (2005)
Employees	1,350
Subsidiaries	Tianjin Tianshi Biological Development Co., Ltd. Tiens Yihai Co., Ltd.
Website	http://www.tiens-bio.com

Tiens Biotech Group USA Inc., Ticker (TBV), operates primarily through its China-based subsidiary Tiens Biological Development CO. Ltd. Tiens Biological has developed and produced seven major product series, of which six comprise nutrition supplement products, and the seventh comprises personal care products. It develops its products at its own product research and development center and conducts the marketing and sales of its products through its affiliated company, which owns 23 branches, representative offices and chain stores. The company's stock is traded on the American Stock Exchange.

1 Joint venture
2 References
3 External links
4 See also

[edit] Joint venture

The company entered into a joint venture with Tianjin Tianshi Pharmaceutical Co., Ltd. in 2004 :

In April 2004 Tiens' wholly-owned subsidiary, Tianshi International Holding Group Ltd. entered into a joint venture agreement with Tianjin Tianshi Pharmaceutical Co., Ltd. to establish Tiens Yihai, a Chinese-Foreign Equity Joint Venture. Located in Shanghai,China, Tiens Yihai is in the business of research and development, production and marketing of nutrition supplements products, home care and personal care products. The total investment amount is projected to be approximately $400million.^[1]